Abstract
Background
Acute disseminated encephalomyelitis (ADEM) is a demyelinating disorder of the central nervous system (CNS). Differentiating ADEM from other inflammatory disorders, such as multiple sclerosis, is not always conclusive using conventional MRI.
Objective
To evaluate longitudinal magnetic resonance spectroscopy (MRS) changes that distinguish ADEM from other inflammatory disorders.
Materials and methods
MRI/MRS scans were performed in seven patients with ADEM during the acute and chronic phases of the disease.
Results
Partial recovery was detected between the acute and chronic phases in choline/creatine ratio. Major elevation of lipids and reduction in myo-inositol/creatine ratio was detected in all patients during the acute phase, followed by a reduction in lipids peak and elevation above normal in myo-inositol/creatine ratio during the chronic phase.
Conclusion
Consistent and unique MRS changes in metabolite ratios between the acute and chronic presentations of the disease were found. To the best of our knowledge, these patterns have not been described in other inflammatory disorders and might assist in the early diagnosis of ADEM.
Similar content being viewed by others
References
Garg RK (2003) Acute disseminated encephalomyelitis. Postgrad Med J 79:11–17
Krupp LB, Banwell B, Tenembaum S (2007) Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 68:S7–12
Leake JA, Albani S, Kao AS et al (2004) Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr Infect Dis J 23:756–764
Murthy JM (2002) Acute disseminated encephalomyelitis. Neurol India 50:238–243
Schwarz S, Mohr A, Knauth M et al (2001) Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology 56:1313–1318
Tenembaum S, Chitnis T, Ness J et al (2007) Acute disseminated encephalomyelitis. Neurology 68:S23–36
Gujar SK, Maheshwari S, Bjorkman-Burtscher I et al (2005) Magnetic resonance spectroscopy. J Neuroophthalmol 25:217–226
Kuker W, Ruff J, Gaertner S et al (2004) Modern MRI tools for the characterization of acute demyelinating lesions: value of chemical shift and diffusion-weighted imaging. Neuroradiology 46:421–426
Banwell B, Ghezzi A, Bar-Or A et al (2007) Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol 6:887–902
Mader I, Wolff M, Nagele T et al (2005) MRI and proton MR spectroscopy in acute disseminated encephalomyelitis. Childs Nerv Syst 21:566–572
Bizzi A, Ulug AM, Crawford TO et al (2001) Quantitative proton MR spectroscopic imaging in acute disseminated encephalomyelitis. AJNR 22:1125–1130
Gabis LV, Panasci DJ, Andriola MR et al (2004) Acute disseminated encephalomyelitis: an MRI/MRS longitudinal study. Pediatr Neurol 30:324–329
Srinivasan R, Sailasuta N, Hurd R et al (2005) Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain 128:1016–1025
Poser CM, Brinar VV (2007) Disseminated encephalomyelitis and multiple sclerosis: two different diseases — a critical review. Acta Neurol Scand 116:201–206
Mascalchi M, Cosottini M, Lolli F et al (2002) Proton MR spectroscopy of the cerebellum and pons in patients with degenerative ataxia. Radiology 223:371–378
Galinska B, Szulc A, Tarasow E et al (2009) Duration of untreated psychosis and proton magnetic resonance spectroscopy (1H-MRS) findings in first-episode schizophrenia. Med Sci Monit 15:CR82–88
Dale RC, Branson JA (2005) Acute disseminated encephalomyelitis or multiple sclerosis: can the initial presentation help in establishing a correct diagnosis? Arch Dis Child 90:636–639
Danielsen ER, Ross B (eds) (1999) Magnetic resonance spectroscopy diagnosis of neurological diseases. CRC, Boca Raton
Fernando KT, McLean MA, Chard DT et al (2004) Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. Brain 127:1361–1369
Brex PA, Parker GJ, Leary SM et al (2000) Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations. J Neurol Neurosurg Psychiatry 68:627–632
Degaonkar MN, Khubchandhani M, Dhawan JK et al (2002) Sequential proton MRS study of brain metabolite changes monitored during a complete pathological cycle of demyelination and remyelination in a lysophosphatidyl choline (LPC)-induced experimental demyelinating lesion model. NMR Biomed 15:293–300
Silver NC, Barker RA, MacManus DG et al (1997) Proton magnetic resonance spectroscopy in a pathologically confirmed acute demyelinating lesion. J Neurol 244:204–207
Gruber S, Frey R, Mlynarik V et al (2003) Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by 1H-MRS at 3 Tesla. Invest Radiol 38:403–408
Coupland NJ, Ogilvie CJ, Hegadoren KM et al (2005) Decreased prefrontal Myo-inositol in major depressive disorder. Biol Psychiatry 57:1526–1534
Frey R, Metzler D, Fischer P et al (1998) Myo-inositol in depressive and healthy subjects determined by frontal 1H-magnetic resonance spectroscopy at 1.5 Tesla. J Psychiatr Res 32:411–420
Hass HG, Nagele T, Seeger U et al (2005) Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS). Z Gastroenterol 43:373–378
Cordoba J, Gottstein J, Blei AT (1998) Chronic hyponatremia exacerbates ammonia-induced brain edema in rats after portacaval anastomosis. J Hepatol 29:589–594
Elberling TV, Danielsen ER, Rasmussen AK et al (2003) Reduced myo-inositol and total choline measured with cerebral MRS in acute thyrotoxic Graves’ disease. Neurology 60:142–145
Wellard RM, Briellmann RS, Prichard JW et al (2003) Myoinositol abnormalities in temporal lobe epilepsy. Epilepsia 44:815–821
Macri MA, Garreffa G, Giove F et al (2004) In vivo quantitative 1H MRS of cerebellum and evaluation of quantitation reproducibility by simulation of different levels of noise and spectral resolution. Magn Reson Imaging 22:1385–1393
Ashwal S, Holshouser B, Tong K et al (2004) Proton spectroscopy detected myoinositol in children with traumatic brain injury. Pediatr Res 56:630–638
Shonk TK, Moats RA, Gifford P et al (1995) Probable Alzheimer disease: diagnosis with proton MR spectroscopy. Radiology 195:65–72
Brand A, Leibfritz D, Richter-Landsberg C (1999) Oxidative stress-induced metabolic alterations in rat brain astrocytes studied by multinuclear nmrNMR spectroscopy. J Neurosci Res 58(4):576–585
Trip SA, Miller DH (2005) Imaging in multiple sclerosis. J Neurol Neurosurg Psychiatry 76(Suppl 3):iii11–18
Brex PA, Gomez-Anson B, Parker GJ et al (1999) Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis. J Neurol Sci 166:16–22
Kapeller P, Brex PA, Chard D et al (2002) Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 8:207–210
Wattjes MP, Harzheim M, Lutterbey GG et al (2008) High field MR imaging and (1)H-MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis: Correlation between metabolic alterations and diagnostic MR imaging criteria. J Neurol 255:56–63
Kapeller P, Ropele S, Enzinger C et al (2005) Discrimination of white matter lesions and multiple sclerosis plaques by short echo quantitative 1H-magnetic resonance spectroscopy. J Neurol 252:1229–1234
Rudick RA (2004) Contemporary diagnosis and management of multiple sclerosis. Handbooks in Health Care, Newtown, PA
Zivadinov R, Cox JL (2007) Neuroimaging in multiple sclerosis. Int Rev Neurobiol 79:449–474
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ben Sira, L., Miller, E., Artzi, M. et al. 1H-MRS for the diagnosis of acute disseminated encephalomyelitis: insight into the acute-disease stage. Pediatr Radiol 40, 106–113 (2010). https://doi.org/10.1007/s00247-009-1372-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-009-1372-9